Clinical Trial Update: A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (UPSTREAM MG) is evaluating telitacicept for generalized myasthenia gravis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Vor Biopharma | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: RECRUITING